Related references
Note: Only part of the references are listed.A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC
N. G. Chau et al.
ANNALS OF ONCOLOGY (2012)
Phase 2 Study of Everolimus Monotherapy in Patients With Nonfunctioning Neuroendocrine Tumors or Pheochromocytomas/Paragangliomas
Do-Youn Oh et al.
CANCER (2012)
Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review
Scott A. Laurie et al.
LANCET ONCOLOGY (2011)
Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland
Lizette Vila et al.
MODERN PATHOLOGY (2009)
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study
L. D. Locati et al.
ORAL ONCOLOGY (2009)
Phase I pharmacokinetic and pharmacodynamic study of the oral mammalian target of rapamycin inhibitor everolimus in patients with advanced solid tumors
Anne O'Donnell et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non-adenoid cystic carcinoma malignant tumors of the salivary glands
Mark Agulnik et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A phase II study of imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands
M. Raphael Pfeffer et al.
ORAL ONCOLOGY (2007)
Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model
Maher N. Younes et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Management of adenoid cystic carcinoma of minor salivary glands
Katherine Triantafillidou et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2006)
Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: A Princess Margaret Hospital phase II consortium study
SJ Hotte et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma
YM Jeng et al.
CANCER LETTERS (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
